Guoping Niu

521 total citations
24 papers, 391 citations indexed

About

Guoping Niu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Guoping Niu has authored 24 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Guoping Niu's work include Cancer-related molecular mechanisms research (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and MicroRNA in disease regulation (3 papers). Guoping Niu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and MicroRNA in disease regulation (3 papers). Guoping Niu collaborates with scholars based in China and United States. Guoping Niu's co-authors include Zhaoji Pan, Li Sun, Juan Zhou, Chen Ding, Fanpeng Zeng, Bing Gu, Feng Gu, Feng Gu, Jian Fang and Hao Lin and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Gene.

In The Last Decade

Guoping Niu

24 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guoping Niu China	12	256	143	74	70	68	24	391
Ching-Yuan Wu Taiwan	11	423 1.7×	136 1.0×	191 2.6×	51 0.7×	68 1.0×	13	598
Jinglue Song China	10	243 0.9×	95 0.7×	97 1.3×	40 0.6×	55 0.8×	16	411
Junfang Lyu Macao	11	258 1.0×	107 0.7×	91 1.2×	50 0.7×	34 0.5×	14	384
Shengnan Ruan China	10	219 0.9×	139 1.0×	88 1.2×	77 1.1×	51 0.8×	22	386
Xin Jing China	12	305 1.2×	106 0.7×	173 2.3×	55 0.8×	135 2.0×	28	554
Xiaofei Cao China	11	315 1.2×	173 1.2×	60 0.8×	29 0.4×	64 0.9×	25	411
Chaobo Hu China	5	203 0.8×	98 0.7×	48 0.6×	58 0.8×	65 1.0×	6	342
Ruixiu Zhang China	10	272 1.1×	138 1.0×	202 2.7×	34 0.5×	63 0.9×	18	492
Xiwu Chen United States	10	194 0.8×	93 0.7×	63 0.9×	49 0.7×	49 0.7×	10	444

Countries citing papers authored by Guoping Niu

Since Specialization

Citations

This map shows the geographic impact of Guoping Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoping Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoping Niu more than expected).

Fields of papers citing papers by Guoping Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoping Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoping Niu. The network helps show where Guoping Niu may publish in the future.

Co-authorship network of co-authors of Guoping Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Guoping Niu. A scholar is included among the top collaborators of Guoping Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoping Niu. Guoping Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Lu, Yuting Ma, Yue Zhang, et al.. (2024). Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway. International Journal of Immunopathology and Pharmacology. 38. 1210469541–1210469541. 4 indexed citations

Chen, Yongqiang, Lu Zheng, Yue Zhang, et al.. (2024). Tumor cell-derived LC3B+extracellular vesicles mediate the crosstalk between tumor microenvironment and immunotherapy efficacy in hepatocellular carcinoma via the HSP90α-IL-6/IL-8 signaling axis. Clinical Immunology. 261. 109925–109925. 8 indexed citations

Ma, Yuting, Lu Zheng, Yue Zhang, et al.. (2024). Interferon-α induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion. Cytokine. 177. 156555–156555. 7 indexed citations

Pan, Zhaoji, Hao Lin, Fanpeng Zeng, et al.. (2023). Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer. Frontiers in Immunology. 14. 1086898–1086898. 34 indexed citations

Chen, Yanhong, Jiao Zhang, Jia Liu, et al.. (2022). The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients. Journal of Immunology Research. 2022. 1–7. 4 indexed citations

Chen, Yongqiang, Lu Zheng, Juan Zhou, et al.. (2022). Evaluation of plasma LC3B+extracellular vesicles as a potential novel diagnostic marker for hepatocellular carcinoma. International Immunopharmacology. 108. 108760–108760. 17 indexed citations

Fang, Jian, Fanpeng Zeng, Yongqiang Chen, et al.. (2022). The role of hypoxic mesenchymal stem cells in tumor immunity. International Immunopharmacology. 112. 109172–109172. 7 indexed citations

Chen, Yanhong, Yu Fu, Shixin Wang, et al.. (2022). Clinical significance of neutrophil gelatinase-associated lipocalin and sdLDL-C for coronary artery disease in patients with type 2 diabetes mellitus aged ≥ 65 years. Cardiovascular Diabetology. 21(1). 252–252. 12 indexed citations

Fang, Jian, et al.. (2022). TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer. International Immunopharmacology. 110. 109008–109008. 6 indexed citations

10.

Zhang, Rui, et al.. (2022). Plasma CXCL3 Levels Are Associated with Tumor Progression and an Unfavorable Colorectal Cancer Prognosis. Journal of Immunology Research. 2022. 1–7. 11 indexed citations

11.

Fang, Jian, et al.. (2021). The Prognostic and Predictive Significance of circRNA CDR1as in Tumor Progression. Frontiers in Oncology. 10. 549982–549982. 13 indexed citations

12.

Chen, Yanhong, Yongqiang Chen, Jia Liu, et al.. (2020). Identification of Long Noncoding RNAs lnc‐DC in Plasma as a New Biomarker for Primary Sjögren’s Syndrome. Journal of Immunology Research. 2020(1). 9236234–9236234. 10 indexed citations

13.

Pan, Zhaoji, et al.. (2019). The Emerging Role of YAP/TAZ in Tumor Immunity. Molecular Cancer Research. 17(9). 1777–1786. 75 indexed citations

14.

Zhou, Juan, Geng Chen, Jia Liu, et al.. (2018). SPC24 Regulates breast cancer progression by PI3K/AKT signaling. Gene. 675. 272–277. 18 indexed citations

15.

Lu, Tong, Jian Liu, Wangjun Yan, et al.. (2018). RDM1 plays an oncogenic role in human lung adenocarcinoma cells. Scientific Reports. 8(1). 11525–11525. 19 indexed citations

16.

Zhou, Juan, et al.. (2017). Meta-analysis of association between rs1447295 polymorphism and prostate cancer susceptibility. Oncotarget. 8(40). 67029–67042. 2 indexed citations

17.

Zheng, Luping, et al.. (2017). The inhibitory effect of Aconiti Sinomontani Radix extracts on the proliferation and migration of human synovial fibroblast cell line SW982. Journal of Ethnopharmacology. 213. 321–327. 8 indexed citations

18.

Niu, Guoping, et al.. (2017). Systematic identification of key genes and pathways in the development of invasive cervical cancer. Gene. 618. 28–41. 29 indexed citations

19.

Zhou, Juan, Guoping Niu, Chen Ding, et al.. (2016). The effect and clinical efficacy of lienal polypeptide injection combined with FOLFOX chemotherapy regimen in colon cancer patients. Oncology Letters. 12(5). 3191–3194. 4 indexed citations

20.

Sun, Guangming, et al.. (2015). Viral metagenomics analysis of picobirnavirus-positive feces from children with sporadic diarrhea in China. Archives of Virology. 161(4). 971–975. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact